
Infectious Diseases and Immunology @wellcometrust, TB R&D, strengthening regulatory and clinical trial systems. Trustee @britsocimm
Joined July 2019
- Tweets237
- Following329
- Followers488
- Likes2.4K
Dr Divya Shah retweeted
'African Medicines Agency gets $12m boost' via @ResearchProfes
researchprofessionalnews.com…
@NEPAD_Agency @wellcometrust @CChamdimba @divletshah
Dr Divya Shah retweeted
'Fifth of medicines in Africa may be sub-par or fake, research finds' via @guardian
theguardian.com/world/articl…
Dr Divya Shah retweeted
Wishing all the amazing #WomenInImmunology a great #InternationalWomensDay!
We want to celebrate women's contributions to #immunology by shining a spotlight on the diverse & inspiring careers of some of our #BSIcommittee members 🤩
Read their profiles 👉bit.ly/49yHN4a
Dr Divya Shah retweeted
Being part of a #BSIcommittee is a rewarding experience that offers #networking & #ProfessionalDevelopment opportunities 🚀
Interested & want to learn more? Here are some summaries about what our committees do ⤵
Nominate yourself by Fri 1 Mar 🔗bit.ly/47TgTT6
🧵 1/7
Dr Divya Shah retweeted
Regulatory Collaboration Can Strengthen Medicines Access - African Scientific Conference healthpolicy-watch.news/regu…
Dr Divya Shah retweeted
🚨 Launching today! We’ve partnered with @MediaplanetUK on today’s Clinical Trials campaign, launching online and within The New Scientist
Read more here 👉 bitly.ws/34Hkb
#ClinicalTrialsCampaign
Dr Divya Shah retweeted
🇪🇬 Commencing the 6th SCoMRA in Cairo, a dynamic forum amplifying the pulse of medical product regulation in Africa.
Expecting deep dives into challenges, innovation sparks, and game-changing dialogues.
#SCoMRA2023 – at Cairo, Egypt
Dr Divya Shah retweeted
In partnership with @CEPIvaccines, we're funding research teams to establish or validate correlates of protection across 11 diseases.
💰 Level: Up to £5 million per project
💡 Duration: Up to 3 years
🗓 Preliminary application deadline: 6 Feb 2024
This is why... ⤵️ [1/5]
Dr Divya Shah retweeted
Today, the @WHO released its annual report on the state of tuberculosis (TB).
The topline?
TB is still one of the world's deadliest infectious diseases — and the funding needed to change that is falling well short.
But there's been some promising progress... [1/5]🧵⤵️
Dr Divya Shah retweeted
Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing healthpolicy-watch.news/swis…
Dr Divya Shah retweeted
I am honoured and very excited about being selected as CEO of @wellcometrust. I feel privileged to be able to work with Wellcome colleagues to bring discovery science and challenge driven science to society to build a healthier future wellcome.org/news/wellcome-a…
Dr Divya Shah retweeted
🚨 Reminder: deadline approaching soon 👇🏻
5⃣ Days
@NEPAD_Agency @NEPAD_AMRH @WHOAFRO @CChamdimba @divletshah @AnthonyKAPETA @djamila_reis @BoiMokgatla @MNgemera @JPmcOmollo #SCOMRA
🚨 Call for abstracts
6th Biennial Scientific Conference on Medical Products Regulation in Africa (SCoMRA VI)
Deadline: 2 October 2023
+info: nepad.org/event/6th-biennial…
Dr Divya Shah retweeted
🚨 Call for abstracts
6th Biennial Scientific Conference on Medical Products Regulation in Africa (SCoMRA VI)
Deadline: 2 October 2023
+info: nepad.org/event/6th-biennial…
Dr Divya Shah retweeted
📢@goodtrials & #clinicaltrials networks in alliance to promote best practices for #RCTs in low resource settings! #GoodTrialsPrism seeks to enhance evidence quality in Latin America, Southeast Asia & South Africa by applying the principles of good trials
goodtrials.org/the-collabora…
Dr Divya Shah retweeted
Deaths caused by tuberculosis are on the rise.
While some recent vaccine developments are promising, progress has been slow, and the tuberculosis health crisis is escalating.
Here’s what you need to know ⤵️
wellcome.org/news/tuberculos…
Dr Divya Shah retweeted
To make a significant impact on improving human health, #DiscoveryResearch @wellcometrust need to fund research led from a diverse range of countries, perspectives and experiences. If your research is based in Latin America, Africa or Asia, join our webinars to hear how!
The Wellcome #DiscoveryResearch team is hosting a series of funding webinars for researchers in different parts of the world.
🗓️ Researchers in Latin America, 18 July
🗓️ Researchers in Africa, 26 July
🗓️ Researchers in Asia, 2 August
Register here ⤵️
wellcome.org/what-we-do/our-…
Dr Divya Shah retweeted
How can African countries meet ambitions to produce their own vaccines to protect people’s health?
@divletshah, a Research Lead in Wellcome’s Infectious Disease team, highlights the key areas where investment is needed ⤵️ #WorldImmunisationWeek
wellcome.org/news/africa-mus…
Dr Divya Shah retweeted
Tuberculosis (TB) is one of the biggest infectious disease killers globally.
And yet progress has stagnated.
To #EndTB, we need a new approach to research and development that takes investment through to better interventions.
#WorldTBDay
Dr Divya Shah retweeted
📢 Are you an African researcher? Your experience, perception, and opinion on the #research environment and practice is wanted!
Follow the link to the survey aphrc.org/blogarticle/take-o…
Thanks!👏
Are you an African researcher? We seek your experience, perception, and opinion on the research environment and practice. Take the African Research Culture Survey in #English, #French or #Portuguese. @wellcometrust @EvelynGitau @CKyobutungi @Khisa_Anne
aphrc.org/blogarticle/take-o…
Dr Divya Shah retweeted
📢 For those wanting to do some application writing this weekend: 🗓Around 2 weeks left to apply to @wellcometrust for Research Manager post in our infectious disease modelling area 💸🌍
📢 @wellcometrust job alert!
🌍 Do you have an interest in global health, infectious disease + modelling? If yes, we are hiring a Research Manager to join our modelling area
✍️ Please apply if interested + feel free to get in touch
🗓️ Closing date 14 Feb
wellcome.wd3.myworkdayjobs.c…





















